VITAL THERAPIES WKN: A2PHD4 ISIN: US4525EP1011 Kürzel: IMUX Forum: Aktien Thema: Hauptdiskussion

Bis September 2024 finanziert....ist nicht mehr so lange hin 🤔

Und warum ist die Aktie gestern so runter gegangen?

Gibt doch eh ein Desaster. Heute Abend 70cent

Don’t miss our webcast on Immunic's financial results for the third quarter ended September 30, 2023, including a corporate, tomorrow, November 14, at 8:00am ET. To participate, please register in advance. https://imux.com/immunic-to-announce-financial-results-for-the-third-quarter-ended-september-30-2023-and-provide-corporate-update/

Das Handelsvolumen ist unterdurchschnittlich. Morgen die Zahlen. 14 h Präsentation für diejenigen, die Zeit haben. Ich bin optimistisch. Hat sich ja nichts geändert.

Kackaktie

NEW YORK, November 7, 2023 – Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced that the company will release its financial results for the third quarter ended September 30, 2023, including a corporate update, on Tuesday, November 14, 2023, before the opening of the U.S. financial markets. A webcast will follow at 8:00 am ET. To participate in the webcast, please register in advance at: https://imux.zoom.us/webinar/register/WN_AxIAE0pCQ12oMZIiehNKDg or on the “Events and Presentations” section of Immunic’s website at: ir.imux.com/events-and-presentations. Registrants will receive a confirmation email containing a link for online participation or a telephone number for dial in access. An archived replay of the webcast will be available approximately one hour after completion on Immunic’s website at: ir.imux.com/events-and-presentations.